首页> 美国卫生研究院文献>Translational Psychiatry >Neuregulin signaling pathway in smoking behavior
【2h】

Neuregulin signaling pathway in smoking behavior

机译:神经调节蛋白信号通路在吸烟行为中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Understanding molecular processes that link comorbid traits such as addictions and mental disorders can provide novel therapeutic targets. Neuregulin signaling pathway (NSP) has previously been implicated in schizophrenia, a neurodevelopmental disorder with high comorbidity to smoking. Using a Finnish twin family sample, we have previously detected association between nicotine dependence and ERBB4 (a neuregulin receptor), and linkage for smoking initiation at the ERBB4 locus on 2q33. Further, Neuregulin3 has recently been shown to associate with nicotine withdrawal in a behavioral mouse model. In this study, we scrutinized association and linkage between 15 036 common, low frequency and rare genetic variants in 10 NSP genes and phenotypes encompassing smoking and alcohol use. Using the Finnish twin family sample (N=1998 from 740 families), we detected 66 variants (representing 23 LD blocks) significantly associated (false discovery rate P<0.05) with smoking initiation, nicotine dependence and nicotine withdrawal. We comprehensively annotated the associated variants using expression (eQTL) and methylation quantitative trait loci (meQTL) analyses in a Finnish population sample. Among the 66 variants, we identified 25 eQTLs (in NRG1 and ERBB4), 22 meQTLs (in NRG3, ERBB4 and PSENEN), a missense variant in NRG1 (rs113317778) and a splicing disruption variant in ERBB4 (rs13385826). Majority of the QTLs in blood were replicated in silico using publicly available databases, with additional QTLs observed in brain. In conclusion, our results support the involvement of NSP in smoking behavior but not in alcohol use and abuse, and disclose functional potential for 56 of the 66 associated single-nucleotide polymorphism.
机译:了解与诸如上瘾和精神疾病等合并症特征相关的分子过程可以提供新的治疗目标。神经调节蛋白信号通路(NSP)以前已与精神分裂症有关,精神分裂症是一种与吸烟高合并症的神经发育障碍。使用芬兰双胞胎家庭样本,我们先前已检测到尼古丁依赖性与ERBB4(神经调节蛋白受体)之间的关联,以及在2q33的ERBB4基因座上引发吸烟的联系。此外,近来已证明神经调节蛋白3在行为小鼠模型中与尼古丁戒断相关。在这项研究中,我们研究了10个NSP基因和表型中15 036常见,低频和稀有遗传变异之间的关联和联系,包括吸烟和饮酒的表型。使用芬兰双胞胎家庭样本(来自740个家庭的N = 1998),我们检测到66个变异(代表23个LD阻断)与吸烟开始,尼古丁依赖性和尼古丁戒断显着相关(错误发现率P <0.05)。我们在芬兰人口样本中使用表达(eQTL)和甲基化定量特征基因座(meQTL)分析来全面注释相关变体。在66个变体中,我们鉴定了25个eQTL(在NRG1和ERBB4中),22个meQTL(在NRG3,ERBB4和PSENEN中),NRG1中的错义变体(rs113317778)和ERBB4中的剪接破坏变体(rs13385826)。血液中的大多数QTL均使用可公开获得的数据库在计算机上复制,并且在大脑中观察到了其他QTL。总之,我们的研究结果支持NSP参与吸烟行为,但不参与酒精使用和滥用,并揭示了66种相关的单核苷酸多态性中的56种具有功能潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号